Drug Patent Watch

APRIL 10, 2025

"Just spent the morning digging into the world of pharmaceuticals and I'm blown away by the complexities of drafting effective drug patent applications. The team at Drug Patent Watch has done an incredible job of breaking down the key considerations for turning scientific discoveries into market power.

Science 73

Science Marketing Drugs Pharmaceuticals 73

Drug Patent Watch

DECEMBER 18, 2024

As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities. However, because it takes so long to bring a drug to market, the effective patent life is often much shorter.

Pharmaceuticals 93

Pharmaceuticals Drugs Drug Development Marketing 93

Drug Patent Watch

JUNE 17, 2025

"Uncovering Hidden Opportunities: The Secret to Unlocking Pharmaceutical Competitive Intelligence As the pharmaceutical industry continues to evolve, companies are under increasing pressure to stay ahead of the curve. Meet the Orange Book, a treasure trove of data that holds the secrets to pharmaceutical competitive intelligence.

Pharmaceuticals 62

Pharmaceuticals Marketing Drugs 62

BioPharma Drive: Drug Pricing

OCTOBER 13, 2023

Acquired with the buyout of Arena Pharmaceuticals, Velsipity enters a competitive market for ulcerative colitis pills.

FDA Approval 286

FDA Approval FDA Pharmaceuticals Marketing 286

Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. These innovations have started to shift industry perceptions, positioning AI as a transformative tool that could alter how drugs are developed, tested, and brought to market.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

Drug Patent Watch

FEBRUARY 27, 2025

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. This is a nightmare scenario for any pharmaceutical company, and it's a reality that many face every day.

Marketing 52

Marketing Drugs Regulations Pharmaceutical Companies 52

Drug Patent Watch

DECEMBER 10, 2024

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

Government 90

Government Drugs Pharmacy Pharmaceuticals 90

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

Marketing 110

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 110

Drug Patent Watch

SEPTEMBER 26, 2024

The generic drug market is a complex and dynamic environment where multiple factors influence the availability, quality, and pricing of generic drugs. Conducting an effective market analysis is crucial for pharmaceutical companies, policymakers, and healthcare professionals to understand the market dynamics and make informed decisions.

Marketing 104

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 104

Drug Patent Watch

JANUARY 13, 2025

As we delve into the intricate world of biosimilar market dynamics, we’ll explore how these complex molecules are reshaping treatment paradigms across diverse patient populations. ”[1] The global biosimilars market is experiencing exponential growth, with projections indicating it will reach $69.4 from 2020 to 2025[1].

Biosimilars 58

Biosimilars Marketing Treatment Small Molecule 58

Drug Patent Watch

SEPTEMBER 30, 2024

Patent expirations have a significant impact on the pharmaceutical industry, particularly on the generic drug market. When a drug’s patent expires, other manufacturers can produce and market generic versions of the drug, leading to increased competition and lower prices.

Marketing 104

Marketing Drugs Pharmaceuticals 104

Drug Patent Watch

OCTOBER 21, 2024

The pharmaceutical industry is a significant contributor to the global economy, with a substantial portion of its production costs incurred during the development stage. The filing of drug patents in emerging markets is a critical aspect of this protection, as it ensures that companies can recoup their investments and… Source

Marketing 101

Marketing Drugs Pharmaceuticals Production 101

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Drug Development 83

Drug Development Compliance Drugs Pharmaceutical Companies 83

Drug Patent Watch

OCTOBER 30, 2024

The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. These patents can provide opportunities for companies to bring new products to market at a lower cost and with reduced development time.

Pharmaceuticals 96

Pharmaceuticals Production Drugs Marketing 96

Drug Patent Watch

JANUARY 14, 2025

In the fast-paced world of pharmaceuticals, negotiations play a pivotal role in shaping the industry’s landscape. Let’s dive into the intricacies of pharmaceutical negotiations, exploring valuable lessons, current trends, and strategies for success.

Pharmaceuticals 54

Pharmaceuticals Compliance Licensing Licensing 54

Drug Patent Watch

JULY 1, 2024

Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […] Source

Marketing 96

Marketing Pharmaceuticals 96

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. But with the ever-changing landscape of the industry, it can be challenging to stay ahead of the competition.

Marketing 53

Marketing Drugs Production Pharmaceuticals 53

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. Understanding the Pharmaceutical Market Dynamics The pharmaceutical industry is a complex ecosystem where branded drugs and generics coexist, each playing a vital role in patient care and market dynamics.

Licensing 83

Licensing Licensing Drugs Biosimilars 83

Drug Patent Watch

JUNE 18, 2025

"Breaking the Patent Code: How CDMOs Can Unlock a Competitive Edge in the Pharmaceutical Market As the pharmaceutical landscape continues to evolve, Contract Development and Manufacturing Organizations (CDMOs) are under increasing pressure to differentiate themselves and attract high-value clients.

Pharmaceuticals 45

Pharmaceuticals Marketing Production 45

Drug Patent Watch

MARCH 31, 2025

The Future of Healthcare: Unpacking the Global Generic Drug Market As we navigate the ever-changing landscape of the pharmaceutical industry, one thing is clear: the demand for affordable, high-quality medications is on the rise. What do you think is the most significant challenge facing the global generic drug market?

Marketing 86

Marketing Biosimilars Drugs Pharmaceutical Companies 86

Drug Patent Watch

APRIL 23, 2025

Trillion Wake-Up Call for the Pharmaceutical Industry As the pharmaceutical landscape continues to shift, one thing is clear: the expiration of drug patents is no longer a footnote in the industry's financials. From market transformations to innovative business models, we examine the key drivers of success in a post-patent world.

Marketing 81

Marketing Pharma Companies Pharmaceuticals Drugs 81

DrugBank

OCTOBER 4, 2024

Deal Structuring Deal structuring in pharmaceutical M&A requires a balance of financial, legal, and strategic considerations. Intellectual Property Valuation Valuing intellectual property (IP) assets is a critical component of pharmaceutical M&A, as these assets often represent a significant portion of a company's value.

Pharmaceuticals 98

Pharmaceuticals Pharmaceutical Companies Therapies Marketing 98

The Premier Consulting Blog

DECEMBER 10, 2024

Bringing a new therapeutic to market is a complex and multifaceted process culminating in submission and approval of a new drug application (NDA). Validation reports are to be included in a marketing application. Following approval, release testing continues on every lot of drug product prior to release into the market.

Marketing 52

Marketing Production Compliance Regulations 52

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 100

Pharmaceutical Companies Drugs Pharmaceuticals Marketing 100

Drug Patent Watch

DECEMBER 11, 2024

The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. Addressing Competition and Market Dynamics The lack of competition in the generic drug market contributes to price hikes and shortages. GREENER Pharmaceuticals for More Sustainable Healthcare.

Drug Development 93

Drug Development Compliance Drugs Pharmaceuticals 93

Drug Patent Watch

APRIL 17, 2025

"Patent Use Codes: The Hidden Language of Pharmaceutical Innovation As a healthcare professional, have you ever wondered what lies behind the complex world of patent use codes? In this comprehensive analysis, we delve into the world of patent use codes and explore their significance in the pharmaceutical industry.

Pharmaceuticals 53

Pharmaceuticals Production Marketing 53

Drug Patent Watch

JUNE 9, 2025

"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex.

Pharmaceutical Companies 75

Pharmaceutical Companies Drugs Pharmaceuticals Regulations 75

Drugs.com

MARCH 11, 2024

a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a. MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In

Trials 130

Trials Marketing Drugs Pharmaceuticals 130

thought leadership

APRIL 10, 2025

Explore key steps to successfully enter the European pharmaceutical market, including navigating regulatory frameworks, ensuring quality compliance, and obtaining Wholesale Distribution Authorization.

Marketing 59

Marketing Pharmaceuticals Compliance Science 59

Drug Patent Watch

JULY 10, 2024

This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […] Source

Marketing 101

Marketing Pharmaceuticals Research 101

Drug Patent Watch

DECEMBER 8, 2024

The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.

Biosimilars 93

Biosimilars Pharmaceutical Companies Drugs Pharmaceuticals 93

Drug Patent Watch

APRIL 1, 2025

The Biosimilar Revolution: How Europe's Generic Drug Industry is Evolving As we navigate the ever-changing landscape of the pharmaceutical industry, one trend is clear: biosimilars are here to stay. Read the full market analysis on the impact of biosimilars on the generic drug industry in Europe: [link]

Biosimilars 76

Biosimilars Marketing Drugs Government 76

Drug Patent Watch

MARCH 19, 2025

Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. But how can you unlock these strategic investment opportunities in the pharmaceutical industry?

Biosimilars 88

Biosimilars Pharmaceutical Companies Pharmaceuticals Drugs 88

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. “Pharmacognosy is the bridge between traditional medicine and modern pharmaceutical science, offering a treasure trove of potential new drugs waiting to be discovered.”

Drugs 90

Drugs Drug Development Pharmaceuticals Production 90

Drug Patent Watch

JULY 2, 2024

The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […] Source

Marketing 101

Marketing Pharmaceuticals 101

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. New Drug Application (NDA) : Needed for marketing approval of new drugs.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

AUGUST 8, 2023

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding.

Marketing 83

Marketing Pharmaceuticals Drugs 83